Identification and validation of a ferroptosis-related gene to predict survival outcomes and the immune microenvironment in lung adenocarcinoma

Table 2 Six small molecule drugs for high-risk LUAD patients slected from CMAP database

Rank	CAMP name	Enrichment	P-value
5	Phenoxybenzamine	−0.924	0.00004
8	Thioguanosine	−0.914	0.0001
9	Apigenin	−0.906	0.00014
19	Medrysone	−0.73	0.00073
22	Chrysin	−0.913	0.00116
23	Vorinostat	−0.51	0.00192

ISSN: 1475-2867